4.7 Review

Pyroptosis and pyroptosis-inducing cancer drugs

Journal

ACTA PHARMACOLOGICA SINICA
Volume 43, Issue 10, Pages 2462-2473

Publisher

NATURE PUBL GROUP
DOI: 10.1038/s41401-022-00887-6

Keywords

pyroptosis; inflammasome; caspase; GSDMD; GSDME; apoptosis

Funding

  1. Arkansas INBRE program [P20 GM103429]
  2. National Heart, Lung and Blood Institute [HL153876]
  3. National Eye Institute [EY030621]

Ask authors/readers for more resources

This review discusses the roles of the gasdermin protein family in anti-cancer functions and various antitumor drugs that could activate the pyroptosis pathways.
Pyroptosis, an inflammatory form of lytic cell death, is a type of cell death mediated by the gasdermin (GSDM) protein family. Upon recognizing exogenous or endogenous signals, cells undergo inflammasome assembly, GSDM cleavage, the release of proinflammatory cytokines and other cellular contents, eventually leading to inflammatory cell death. In this review, we discuss the roles of the GSDM family for anti-cancer functions and various antitumor drugs that could activate the pyroptosis pathways.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available